These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25123732)

  • 21. Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.
    Tjong FV; Reddy VY
    Circulation; 2017 Apr; 135(15):1458-1470. PubMed ID: 28396380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pacing follow up techniques and trouble shooting during biventricular pacing.
    Vardas PE
    J Interv Card Electrophysiol; 2003 Oct; 9(2):183-7. PubMed ID: 14574030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac rhythm disorders: problems of the present, challenges for the future.
    De Roy L
    Acta Cardiol; 2004; 59 Suppl 1():39-41. PubMed ID: 15291434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.
    Tjong FVY; Koop BE
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):355-361. PubMed ID: 30382341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pacemakers, defibrillators, and direct current cardioversion.
    Sgarbossa EB; Black IW; Maloney JD
    Curr Opin Cardiol; 1993 Jan; 8(1):27-38. PubMed ID: 10148086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leadless technology: a new paradigm for cardiac pacing?
    Zucchelli G; Barletta V; Bongiorni MG
    Minerva Cardioangiol; 2018 Feb; 66(1):113-123. PubMed ID: 28696087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
    Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
    Stanek A; Lelakowski J; Matusik PT
    Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    Madhavan M; Mulpuru SK; McLeod CJ; Cha YM; Friedman PA
    J Am Coll Cardiol; 2017 Jan; 69(2):211-235. PubMed ID: 28081830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of expanding indications on the safety of pacemakers and defibrillators.
    Maisel WH; ; ;
    Card Electrophysiol Rev; 2003 Jan; 7(1):30-2. PubMed ID: 12766513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leadless pacing: present and future of cardiac stimulation].
    Piro A; Lavalle C; Della Rocca DG; Scarparo P; Mancone M; Maestrini V; Di Biase L; Natale A; Fedele F
    G Ital Cardiol (Rome); 2019 Jan; 20(1):32-40. PubMed ID: 30638213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
    Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
    Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remote Monitoring of Cardiac Implantable Electronic Devices: What is the Evidence?
    Reinhardt A; Ventura R
    Curr Heart Fail Rep; 2023 Feb; 20(1):12-23. PubMed ID: 36701019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leadless cardiac pacing systems: current status and future prospects.
    Beurskens NEG; Breeman KTN; Dasselaar KJ; Meijer AC; Quast ABE; Tjong FVY; Knops RE
    Expert Rev Med Devices; 2019 Nov; 16(11):923-930. PubMed ID: 31657945
    [No Abstract]   [Full Text] [Related]  

  • 36. Device therapy for heart failure.
    Boehmer JP
    Am J Cardiol; 2003 Mar; 91(6A):53D-59D. PubMed ID: 12670643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
    van Veldhuisen DJ; Maass AH; Priori SG; Stolt P; van Gelder IC; Dickstein K; Swedberg K
    Eur J Heart Fail; 2009 Dec; 11(12):1143-51. PubMed ID: 19884129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.
    Gupta N; Kiley ML; Anthony F; Young C; Brar S; Kwaku K
    J Am Heart Assoc; 2016 Mar; 5(3):e002798. PubMed ID: 26961369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future of implantable devices for cardiac rhythm management.
    Lau CP; Siu CW; Tse HF
    Circulation; 2014 Feb; 129(7):811-22. PubMed ID: 24550552
    [No Abstract]   [Full Text] [Related]  

  • 40. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.